133 related articles for article (PubMed ID: 29628022)
1. Vitamin E supplementation improves high-densitiy lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysis
.
Mune M; Uto-Kondo H; Iteya I; Fujii Y; Ikeda S; Ikewaki K
Clin Nephrol; 2018 Sep; 90(3):212-221. PubMed ID: 29628022
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients.
Daud ZA; Tubie B; Sheyman M; Osia R; Adams J; Tubie S; Khosla P
Vasc Health Risk Manag; 2013; 9():747-61. PubMed ID: 24348043
[TBL] [Abstract][Full Text] [Related]
3. Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.
Costacou T; Levy AP; Miller RG; Snell-Bergeon J; Asleh R; Farbstein D; Fickley CE; Pambianco G; de la Vega R; Evans RW; Orchard TJ
Acta Diabetol; 2016 Apr; 53(2):243-50. PubMed ID: 26002590
[TBL] [Abstract][Full Text] [Related]
4. Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure.
Baldi S; Innocenti M; Frascerra S; Nannipieri M; Lippi A; Rindi P; Ferrannini E
J Nephrol; 2013; 26(3):549-55. PubMed ID: 22941872
[TBL] [Abstract][Full Text] [Related]
5. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans.
Montazerifar F; Hashemi M; Karajibani M; Dikshit M
J Med Food; 2010 Dec; 13(6):1490-3. PubMed ID: 21091256
[TBL] [Abstract][Full Text] [Related]
6. Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.
Asleh R; Blum S; Kalet-Litman S; Alshiek J; Miller-Lotan R; Asaf R; Rock W; Aviram M; Milman U; Shapira C; Abassi Z; Levy AP
Diabetes; 2008 Oct; 57(10):2794-800. PubMed ID: 18599520
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients.
Castilla P; Dávalos A; Teruel JL; Cerrato F; Fernández-Lucas M; Merino JL; Sánchez-Martín CC; Ortuño J; Lasunción MA
Am J Clin Nutr; 2008 Apr; 87(4):1053-61. PubMed ID: 18400731
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.
Yamamoto S; Yancey PG; Ikizler TA; Jerome WG; Kaseda R; Cox B; Bian A; Shintani A; Fogo AB; Linton MF; Fazio S; Kon V
J Am Coll Cardiol; 2012 Dec; 60(23):2372-9. PubMed ID: 23141484
[TBL] [Abstract][Full Text] [Related]
9. Comment on "Vitamin E supplementation improves high-density lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysis" by Mune et al. Clinical Nephrology DOI 10.5414/CN109197 e-pub: April 9, 2018.
Ravarotto V; Simioni F; Pagnin E; Calò LA
Clin Nephrol; 2019 May; 91(5):323-324. PubMed ID: 30563608
[No Abstract] [Full Text] [Related]
10. Effects of vitamin supplementation on microcirculatory disturbance in hemodialysis patients without peripheral arterial disease.
Sato M; Matsumoto Y; Morita H; Takemura H; Shimoi K; Amano I
Clin Nephrol; 2003 Jul; 60(1):28-34. PubMed ID: 12872855
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of atherogenic apo B-48-dependent hyperlipidemia and high density lipoprotein remodeling induced by vitamin C and E combination and their beneficial effect on lethal ischemic heart disease in mice.
Contreras-Duarte S; Chen P; Andía M; Uribe S; Irarrázaval P; Kopp S; Kern S; Marsche G; Busso D; Wadsack C; Rigotti A
Biol Res; 2018 Sep; 51(1):34. PubMed ID: 30219096
[TBL] [Abstract][Full Text] [Related]
12. Lipoperoxidation and hemodialysis.
Ramos R; Martínez-Castelao A
Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
[TBL] [Abstract][Full Text] [Related]
13. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin E supplementation on serum and high-density lipoprotein-cholesterol in renal patients on maintenance hemodialysis.
Chapkin RS; Haberstroh B; Liu T; Holub BJ
Am J Clin Nutr; 1983 Aug; 38(2):253-6. PubMed ID: 6881082
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin E-coated dialysis membranes on anemia, nutrition and dyslipidemia status in hemodialysis patients: a meta-analysis.
Huang J; Yi B; Li AM; Zhang H
Ren Fail; 2015 Apr; 37(3):398-407. PubMed ID: 25585953
[TBL] [Abstract][Full Text] [Related]
17. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
Refaat H; Sany D; Mohab A; Ezzat H
Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
[TBL] [Abstract][Full Text] [Related]
18. [Effect of vitamin E supplementation on the vitamin content of lipoprotein in young men and women].
Somogyi A; Herold M; Kocsis I; Nagy G; Somfai G; Studinger P
Orv Hetil; 2005 Aug; 146(35):1813-8. PubMed ID: 16187540
[TBL] [Abstract][Full Text] [Related]
19. Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.
Ansari MR; Maheshwari N; Shaikh MA; Laghari MS; ; Lal K; Ahmed K
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):21-5. PubMed ID: 22237213
[TBL] [Abstract][Full Text] [Related]
20. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Navarro JF; Mora C; Muros M; García-Idoate G
Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
